Cutia Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Cutia Therapeutics has a total shareholder equity of CN¥1.2B and total debt of CN¥210.3M, which brings its debt-to-equity ratio to 17.7%. Its total assets and total liabilities are CN¥1.5B and CN¥319.4M respectively.
Belangrijke informatie
17.7%
Verhouding schuld/eigen vermogen
CN¥210.33m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥1.04b |
| Aandelen | CN¥1.19b |
| Totaal verplichtingen | CN¥319.44m |
| Totaal activa | CN¥1.51b |
Recente financiële gezondheidsupdates
Analyse van de financiële positie
Kortlopende schulden: 2487's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥237.8M).
Langlopende schulden: 2487's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥81.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 2487 has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if 2487's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 2487 has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if 2487 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.